PDL BioPharma, Inc.
PDLIV
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 08/31/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | 09/30/2019 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -62.99% | -65.74% | -53.79% | -26.61% |
| Total Receivables | -- | -30.36% | -28.18% | -12.79% | 1.17% |
| Inventory | -- | -22.32% | -32.19% | 98.45% | 67.34% |
| Prepaid Expenses | -- | 108.73% | 92.75% | -49.41% | -23.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 289,326.00% | 332,648.00% | 8.02% | -- |
| Total Current Assets | -- | 23.98% | 15.44% | -39.31% | -19.86% |
|
|
|||||
| Total Current Assets | -- | 23.98% | 15.44% | -39.31% | -19.86% |
| Net Property, Plant & Equipment | -- | -64.56% | -63.70% | 5.78% | -9.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -96.57% | -96.97% | -3.75% | -16.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 3.60% | 116.97% | -33.25% | -85.94% |
| Total Assets | -- | -41.53% | -28.56% | -25.72% | -12.12% |
|
|
|||||
| Total Accounts Payable | -- | -76.21% | -57.93% | 5.77% | 47.11% |
| Total Accrued Expenses | -- | -11.96% | -49.48% | 24.44% | -34.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 140.80% | 162.92% | -23.21% | -12.13% |
| Total Other Current Liabilities | -- | 140.80% | 162.92% | -23.21% | -12.13% |
| Total Current Liabilities | -- | -5.48% | -3.64% | -12.91% | -12.31% |
|
|
|||||
| Total Current Liabilities | -- | -5.48% | -3.64% | -12.91% | -12.31% |
| Long-Term Debt | -- | -89.49% | -89.49% | -78.14% | 7.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -11.13% | -12.17% | -14.10% | -29.16% |
| Total Liabilities | -- | -55.27% | -53.56% | -47.43% | -7.07% |
|
|
|||||
| Common Stock & APIC | -- | -1.56% | -2.67% | -8.94% | -21.78% |
| Retained Earnings | -- | -36.04% | -21.42% | -19.04% | -11.83% |
| Treasury Stock & Other | -- | 30.36% | 29.74% | 21.23% | -2.85% |
| Total Common Equity | -- | -36.79% | -20.20% | -18.72% | -13.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | -36.79% | -20.20% | -18.72% | -13.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -335.86% | -121.61% | -- | -- |
| Total Equity | -- | -36.88% | -20.28% | -18.70% | -13.79% |
|
|
|||||